Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction
Patrícia A. Reis(Fundação Oswaldo Cruz), Fernando A. Bozza(D’Or Institute for Research and Education), Joana C. d’Avila(Universidade Iguaçu), Pedro CB Alexandre(Fundação Oswaldo Cruz), Tarek Sharshar(Strateji Araşdırmalar Mərkəzi), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Vanessa Estato(Fundação Oswaldo Cruz), Franck Verdonk(Inserm), Luciana Domett Siqueira(Universidade Federal do Rio de Janeiro), Fabrice Chrétien(Université Paris Cité), Eduardo Tibiriçá(Instituto Nacional de Cardiologia), Bárbara Antunes(Fundação Oswaldo Cruz)
Cited by 92
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492